Patients in the US with the ultra-rare disease WHIM syndrome now have their first approved treatment, after X4 Pharma’s Xolremdi was given a green light by the FDA. Oral CXCR4 antagonist Xolremdi ...
At the Dawn of Generative AI Era: A Tutorial-cum-Survey on New Frontiers in 6G Wireless Intelligence
Abstract: As we transition from the 5G epoch, a new horizon beckons with the advent of 6G, seeking a profound fusion with novel communication paradigms and emerging technological trends, bringing once ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results